Table 1.
Patient characteristics in upper urinary tract transitional cell carcinoma
| Median (range) or n (%) | ||||
|---|---|---|---|---|
|
| ||||
| Total n=114 | Renal pelvis n=61 | Ureter n=53 | p value | |
|
|
||||
| Age | 71.0 (44–84) | 71.0 (47–84) | 71.0 (44–81) | 0.917* |
| M:F | 88:26 | 50:11 | 38:15 | 0.192† |
| DM | 18 (15.8) | 13 (21.3) | 5 (9.4) | 0.083† |
| Hydronephrosis | ||||
| None | 47 (41.2) | 39 (63.9) | 8 (15.1) | 0.0001† |
| Mild | 30 (26.3) | 11 (18.0) | 19 (35.8) | |
| Moderate | 17 (14.9) | 4 (6.6) | 13 (24.5) | |
| Severe | 20 (17.5) | 7 (11.5) | 13 (24.5) | |
| pT stage | ||||
| Ta | 22 (19.3) | 13 (21.3) | 9 (17.0) | 0.062† |
| T1 | 23 (20.2) | 15 (24.6) | 8 (15.1) | |
| T2 | 26 (22.8) | 8 (13.1) | 18 (34.0) | |
| T3 | 43 (37.7) | 25 (41.0) | 18 (34.0) | |
| Grade | ||||
| Low | 31 (27.2) | 16 (26.2) | 15 (28.3) | 0.804† |
| High | 83 (72.8) | 45 (73.8) | 38 (71.7) | |
| Adjuvant treatment | ||||
| None | 56 (49.1) | 31 (50.8) | 25 (47.2) | 0.498† |
| Chemotherapy | 56 (49.1) | 30 (49.2) | 26 (49.1) | |
| Radiotherapy | 1 (0.9) | 0 (0) | 1 (1.9) | |
| Chemoradiotherapy | 1 (0.9) | 0 (0) | 1 (1.9) | |
| Type of recurrence | ||||
| None | 43 (37.7) | 25 (41.0) | 18 (34.0) | 0.348† |
| Local recurrence | 13 (11.4) | 4 (6.6) | 9 (17.0) | |
| Distant metastasis | 12 (10.5) | 6 (9.8) | 6 (11.3) | |
| Bladder recurrence | 46 (40.4) | 26 (42.6) | 20 (37.7) | |
*
Student’s t-test;
†
Chi-squre test; M: male; F: female; DM: diabetes mellitus.